DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
M•• B•••• L••
Healthcare & Pharmaceuticalsgroup grade Con a schedule nowsponsor unattributed
Principal held
at least $33.1M
sum of BDC pieces, a lower bound
Fair value
$31.9M
97c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Jun 30, 2029
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $33.1M | 97c | SOFR+538 bp | Jun 30, 2029 | 2 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| O••• D••••• L•••••• B•• F••• | term loan first lien F•••• L••• T••• L••• R•••••••• R••• and S••••• 6M S••• +5.38% F•••• 1.00% I••••••• R••• 9. | $24.1M | $22.9M 96c | SOFR+538 bp |
| S••••• P•••• S•••••••• L•••••• F••• | term loan first lien 1st L•••/S•••••• L•••• I••••••••• 1st L••• T••• L••• I••••••• H••••••••• P•••••••• & Servi | $9.1M | $9.0M 100c | SOFR+538 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $33.1M | $31.9M | 97c | 0 |
| Mar 31, 2026 | 2 | $33.2M | $32.0M | 97c | 0 |
| Dec 31, 2025 | 1 | $9.1M | $9.1M | 101c | 0 |
| Sep 30, 2025 | 2 | $33.4M | $31.9M | 96c | 0 |
| Jun 30, 2025 | 2 | $33.5M | $33.2M | 100c | 0 |
| Mar 31, 2025 | 2 | $33.0M | $32.9M | 101c | 0 |
| Dec 31, 2024 | 2 | $33.0M | $33.0M | 101c | 0 |
| Sep 30, 2024 | 2 | $33.1M | $33.0M | 101c | 0 |
| Jun 30, 2024 | 2 | $33.2M | $33.0M | 101c | 0 |
| Mar 31, 2024 | 2 | $33.3M | $33.2M | 101c | 0 |
| Dec 31, 2023 | 2 | $33.4M | $33.3M | 101c | 0 |
| Sep 30, 2023 | 1 | $24.8M | $24.6M | 101c | 0 |
| Jun 30, 2023 | 1 | $24.8M | $24.8M | 102c | 0 |
| Dec 31, 2022 | 2 | $33.7M | $33.2M | 100c | 0 |
What changed
- Marked down (one lender)Sep 30, 2025
- Maturity extended (observed)Dec 31, 2024
- Spread changed (observed)Sep 30, 2024
- Maturity extended (observed)Sep 30, 2024
- Maturity shortened (observed)Sep 30, 2024
- Maturity extended (observed)Dec 31, 2023
- Maturity extended (observed)Dec 31, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- M•• B••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it